retatrutide triple hormone receptor agonist weight loss Medscape | Retatrutide, Eli Lilly's first-in-class agonist, delivered meaningful at 80 weeks in all doses in the Retatrutide peptide for weight loss
Description
Those who are overweight or obese and take these medications face a sevenfold increase in risk
Fasting glucose reductions also favored tirzepatide (approximately -68 mg/dL vs -59 mg/dL)
Diabetologia 56: 26792687, 2013
American Journal of Medicine 1997: 103: 491-7 8
What happens when you stop weight loss medication like mounjaro and wegovy
[DOI] [PubMed] [Google Scholar] 45.Sheets C, Peden M, Guy J
